Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)

NCT06424210 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06424210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06424210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1)
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
February 15, 2023
Completion date
June 1, 2023
Enrollment
163 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, metastatic disease